Exactly right. The pros are waiting til they get more info on the science(MOS) and financial ( where is the money coming from other than dilution). That said, it is not because they necessarily think the most recent science data is mediocre.
Some posters on this board are very good at cutting and pasting and that is it. When they start to say original things or analyze they show their total lack of both science and business sense
I have a feeling that the so called "biotech analysts" don't really have much understanding of the science here. It is not a small molecule, not the same old, same old stuff, they are used to seeing. Immunotherapy for cancer still is not believed by some people. So I would say you are correct in that they will wait until it has been proven without a doubt before going out on a limb. So what are they good for??